Nolvadex (Tamoxifen Citrate)

Tamoxifen citrate binds to estrogen receptors, especially in breast tissue, acting as an antagonist that prevents estrogen from stimulating cell proliferation. While it blocks estrogen in the breast, it can act as a partial agonist in other tissues, providing a balanced hormonal effect that helps inhibit tumor growth and manage hormone‑related conditions.

The dosage of Nolvadex is determined by the prescribing clinician based on the specific indication, patient characteristics, and treatment goals. Physicians tailor the regimen to each individual, and patients should follow the prescribed instructions without making any changes on their own.

Nolvadex is classified as pregnancy category D, indicating evidence of risk to the fetus. It should not be used during pregnancy, and effective contraception is required for women of childbearing potential. Use while breastfeeding is not recommended because the drug can pass into breast milk and affect the infant.

To request Nolvadex, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will verify trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Nolvadex belongs to the selective estrogen receptor modulator (SERM) class, differing from aromatase inhibitors and chemotherapy agents. While aromatase inhibitors lower overall estrogen levels, tamoxifen blocks estrogen receptors directly. This mechanism makes it useful in pre‑menopausal patients and for certain preventive strategies, whereas other agents may be preferred in post‑menopausal settings.

Nolvadex tablets should be stored at room temperature, below 25 °C, in their original packaging. Protect them from moisture, excessive heat and direct sunlight to maintain stability and potency throughout the shelf life.

Nolvadex is taken orally, usually as a tablet swallowed with water. The exact timing and whether it should be taken with food depend on the prescribing physician’s instructions. Consistency in administration helps maintain steady drug levels in the body.

Serious risks include the development of deep‑vein thrombosis or pulmonary embolism, endometrial cancer, severe liver injury, and visual disturbances. Patients should be monitored for signs of clotting, abnormal uterine bleeding, liver dysfunction, or changes in vision, and report any such symptoms promptly.

Nolvadex is contraindicated in pregnant women, individuals with a known hypersensitivity to tamoxifen or its excipients, and patients with a history of thromboembolic disorders unless the benefits outweigh the risks. Clinicians should also exercise caution in patients with liver disease or uncontrolled diabetes.